Description: Advanced Biomedical Technologies, Inc. is engaged in the business of designing, developing and manufacturing of self-reinforced, re-absorbable biodegradable internal fixation devices. The Company's primary products include absorbable polyamide (PA) osteosynthesis devices made of a PA material. These advanced materials are used in surgical screws, binding wires, rods and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials, and its PA Mini-Screws are under animal test. The Company's PA products, such as screws, rods, and binding wires, consist of fibers and high molecular polymers, which are designed to facilitate healing of complex fractures in many areas of the human skeletal system. As of October 31, 2016, the Company had completed the design and production of testing mini-screws using its PA material.
Home Page: abtlafleur.com
200 Park Avenue
New York,
NY
10166
United States
Phone:
718 766 7898
Officers
Name | Title |
---|---|
Ms. Hui Wang | CEO, Controller & Director |
Mr. Chi Ming Yu | Pres, Treasurer, Compliance Officer & Director |
Mr. Kai Gui | Sec., CFO, COO & Director |
Prof. Puyi Sheng M.D., Ph.D. | Chief Medical Officer |
Prof. Shangli Liu M.D., Ph.D. | Chairman of Scientific Board & Chief Medical Advisor of Greater China |
Dr. John Thomas Lynch Jr. | Chief Officer of Dental Technologies |
Exchange: PINK
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 0 |
Price-to-Sales TTM: | 31.9657 |
IPO Date: | |
Fiscal Year End: | October |
Full Time Employees: | 17 |